This study tests a new combination of drugs for people with a slow-growing lymphoma that has a high tumor burden. Participants receive a targeted pill (tazemetostat) along with two standard chemotherapy drugs, but with fewer cycles of one chemo to reduce side effects. The goal is…
Phase: PHASE1, PHASE2 • Sponsor: Vaishalee Kenkre • Aim: Disease control
Last updated May 17, 2026 10:36 UTC